Recent advances in small-molecule inhibitors targeting influenza virus glycoproteins / 药学学报
Acta Pharmaceutica Sinica
;
(12): 3254-3269, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-999070
ABSTRACT
Hemagglutinin and neuraminidase, two important glycoproteins on the surface of influenza virus, play a considerable role in the entry and release stage of the viral life cycle, respectively. With in-depth investigation of influenza virus glycoproteins and the continuous innovation of drug discovery strategies, a new generation of glycoproteins inhibitors have been continuously discovered. From the point of view of medicinal chemistry, this review summarizes the current advances in seeking small-molecule inhibitors targeting influenza virus glycoproteins, hoping to provide valuable guidance for future development of novel antiviral drugs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS